Press Releases
SAN DIEGO and PENNINGTON, N.J., Nov. 12, 2019 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (Nasdaq:ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced outcomes from a safety and biomarker analysis on its lead product candidate, TAVO™, at the Society for Immunotherapy of C
Read more...12 November 2019
SAN DIEGO, Nov. 12, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced financial results for the three and nine months ended September 3
Read more...12 November 2019
RIDGEFIELD, Conn. and INDIANAPOLIS, Nov. 12, 2019 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced the initiation of EMPULSE, the sixth phase III study in the Jardiance® (empagliflozin) heart failure program. The study will assess whether in-hospital administration of Jardiance 10 mg daily improves heart failure
Read more...12 November 2019
ATLANTA, Nov. 12, 2019 /PRNewswire/ -- Parallel, formerly Surterra Wellness, a company that is pioneering human well-being through its proprietary cannabinoid brands, science and technology-led innovation, today announced that Kevin Fisher has been named Chief Operating Officer (COO), effective immediately. As COO, Fisher will ha
Read more...12 November 2019
ALLSCHWIL, Switzerland, Nov. 12, 2019 /PRNewswire/ -- Actelion Pharmaceuticals Ltd, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has announced its decision to voluntarily withdraw the European and other health authority filings still under review to extend the indication of OPSUMIT® (macitentan) to include the treatment of adu
Read more...12 November 2019
SEATTLE, Nov. 12, 2019 /PRNewswire/ -- Faraday Pharmaceuticals, a biopharmaceutical company focused on the development of elemental reducing agents for critical care medicine, today announced that top-line results from its Phase 2 trial of FDY-5301 will be presented at the American Heart Association (AHA) Scientific Sessions 2019 taking place
Read more...12 November 2019
LOS ALTOS, Calif., Nov. 12, 2019 /PRNewswire/ -- Univfy, an AI and machine learning platform company with a mission to expand in-vitro fertilization (IVF) access, will be presenting at the upcoming con
Read more...IRVINE, Calif., Nov. 12, 2019 /PRNewswire/ -- Good Culture®, the brand that has revolutionized the dairy aisle with its clean label cottage cheese and probiotic sour cream,
Read more...TULSA, Okla., Nov. 12, 2019 /PRNewswire/ -- The APCO Group, parent company of APCO MED, APCO CBD and APCO Media is proud to announce the November 15th, 2019 "Grand Opening of Gratitude" - a celebration for its first medical marijuana dispensary concept store located at 2606 S. Sheridan Rd., Suite A Tulsa, Oklah
Read more...Study holds promise to better predict immunotherapy responses in bladder cancer ANTWERP, Belgium, Nov. 12, 2019 /PRNewswire/ - Today in
Read more...